Summary:
Click image to enlarge
Epstein-Barr virus (EBV) is a highly contagious virus in the herpesvirus family, primarily spread through saliva, and is the main cause of infectious mononucleosis (mono). EBV is also linked to certain cancers (like lymphoma) and autoimmune diseases, though many people remain asymptomatic.
We are looking for healthy adults aged 18-55 years to participate in a clinical trial for a new mRNA EBV vaccine. This study will evaluate the safety of the vaccine and its ability to stimulate an immune response against EBV. If you're interested in learning more or want to see if you qualify, click Apply to get started!
Qualified Participants Must:
• Healthy participants 12-55 years of age
Qualified Participants May Receive:
Qualified participants will received:
- Compensation: Get reimbursement up to $2,800 for time and travel
- Comprehensive Support: Regular check-ins and assessments to ensure your health is a priority. Our trial is conducted by experienced healthcare professionals dedicated to your well-being.
- Free study medications: Study vaccines for Epstein-Barr are given at no cost!